Capstone Investment Advisors
DXCM icon

Capstone Investment Advisors’s DexCom DXCM Stock Holding History

Capstone Investment Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269K Sell
4,000
-2,800
-41% -$187K ﹤0.01% 1511
2026
Q1 		$427K Sell
6,800
-2,400
-26% -$167K ﹤0.01% 1218
2025
Q4 		$611K Sell
9,200
-5,100
-36% -$330K ﹤0.01% 1074
2025
Q3 		$962K Sell
14,300
-4,500
-24% -$356K ﹤0.01% 1049
2025
Q2 		$1.64M Buy
18,800
+7,600
+68% +$596K ﹤0.01% 708
2025
Q1 		$765K Sell
11,200
-67,900
-86% -$5.54M ﹤0.01% 959
2024
Q4 		$6.15M Buy
79,100
+52,700
+200% +$3.9M 0.01% 474
2024
Q3 		$1.77M Buy
26,400
+500
+2% +$41.1K 0.01% 775
2024
Q2 		$2.94M Buy
25,900
+12,300
+90% +$1.56M 0.01% 603
2024
Q1 		$1.89M Sell
13,600
-10,200
-43% -$1.28M 0.01% 809
2023
Q4 		$2.95M Buy
23,800
+12,300
+107% +$1.26M 0.01% 692
2023
Q3 		$1.07M Buy
11,500
+1,300
+13% +$147K ﹤0.01% 958
2023
Q2 		$1.31M Buy
10,200
+500
+5% +$60.5K 0.01% 768
2023
Q1 		$1.13M Buy
9,700
+2,100
+28% +$235K 0.01% 756
2022
Q4 		$861K Buy
7,600
+2,100
+38% +$231K 0.01% 981
2022
Q3 		$443K Sell
5,500
-15,400
-74% -$1.3M ﹤0.01% 1313
2022
Q2 		$1.56M Sell
20,900
-7,100
-25% -$648K 0.01% 855
2022
Q1 		$3.58M Sell
28,000
-25,200
-47% -$2.76M 0.01% 817
2021
Q4 		$7.14M Sell
53,200
-400
-0.7% -$57.5K 0.01% 720
2021
Q3 		$7.33M Sell
53,600
-400
-0.7% -$50.4K 0.01% 722
2021
Q2 		$5.76M Buy
54,000
+5,200
+11% +$499K 0.01% 691
2021
Q1 		$4.38M Buy
48,800
+21,200
+77% +$1.99M 0.01% 684
2020
Q4 		$2.55M Buy
27,600
+1,600
+6% +$143K 0.01% 804
2020
Q3 		$2.68M Buy
26,000
+2,400
+10% +$251K 0.01% 716
2020
Q2 		$2.39M Buy
+23,600
New +$2.11M 0.02% 654

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capstone Investment Advisors's DXCM Position: Q2 2026 in Review

Capstone Investment Advisors reduced its DexCom (DXCM) stake by 78% in Q2 2026, selling an estimated $2.84M and leaving 12,147 shares worth $818K. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

Capstone Investment Advisors first reported a position in DXCM in Q4 2020 and has held it in 17 quarters since. The position peaked at $8.04M in Q3 2025. 975 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Capstone Investment Advisors held 12,147 shares of DexCom worth $818K as of Q2 2026.
  • Capstone Investment Advisors sold 42,568 DexCom shares in Q2 2026, an estimated $2.84M.
  • DexCom made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1025 holding.
  • Capstone Investment Advisors first reported a position in DexCom in Q4 2020 and has held it in 17 quarters since.
  • Capstone Investment Advisors's DexCom position peaked at $8.04M in Q3 2025.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.